| Product NDC: | 63304-794 |
| Proprietary Name: | Flecainide Acetate |
| Non Proprietary Name: | Flecainide |
| Active Ingredient(s): | 50 mg/1 & nbsp; Flecainide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63304-794 |
| Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076421 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040228 |
| Package NDC: | 63304-794-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, UNIT-DOSE (63304-794-01) |
| NDC Code | 63304-794-01 |
| Proprietary Name | Flecainide Acetate |
| Package Description | 100 TABLET in 1 BOTTLE, UNIT-DOSE (63304-794-01) |
| Product NDC | 63304-794 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Flecainide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20040228 |
| Marketing Category Name | ANDA |
| Labeler Name | Ranbaxy Pharmaceuticals Inc. |
| Substance Name | FLECAINIDE ACETATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |